Abstract
In this issue of Cell Chemical Biology, Zhan etal. report dual-pharmacophore molecules ("artezomibs"), combining an artemisinin and proteasome inhibitor that exhibit potent activity against both wild-type and drug-resistant malarial parasites.1 This study indicates that artezomibs offer a promising approach to combat drug resistance encountered by current antimalarial therapies.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have